Genome Editing Market size was valued at USD 9.47 billion in 2024 and is expected to exceed USD 64.48 billion by the end of 2037, registering over 15.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of genome editing is evaluated at USD 10.67 billion. The market's growth is primarily due to the high prevalence of cancer around the globe. In 2020, the World Health Organization reported that approximately 10 million people succumbed to cancer worldwide. The most common types of cancer that caused fatalities were lung cancer, which accounted for 1.8 million deaths, colon and rectal cancer with 916,000 deaths, liver cancer with 830,000 deaths, stomach cancer with 769,000 deaths, and breast cancer with 685,000 deaths. Furthermore, diseases like human papillomavirus (HPV) and hepatitis have been found to cause about 30% of cancer cases in low- and middle-income countries.
The market is growing due to advancements in gene editing tools, government funding, and an increase in genomics projects. The rise in cancer and genetic diseases and the development of CRISPR-based diagnostic tools for COVID-19 are also contributing. CRISPR-Cas9 dominates with 65% revenue share, expected to reach 70% by 2025. High device costs and ethical concerns hinder growth, but emerging markets and drug discovery opportunities hold promise.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
15.9% |
|
Base Year Market Size (2024) |
USD 9.47 billion |
|
Forecast Year Market Size (2035) |
USD 64.48 billion |
|
Regional Scope |
|
Application (Cell Line Engineering, Genetic Engineering, Drug Discovery, Gene-modified Cell Therapy, Diagnostics)
Genetic engineering segment in the genome editing market is expected to garner a significant share in the year 2037. The growth of this segment can be attributed to advancements in gene editing technologies. Recent progress in gene editing technologies, such as CRISPR-Cas9, has significantly improved the accuracy and effectiveness of genetic engineering. As a result, new opportunities for gene therapy, drug development, and agricultural applications have emerged.
End Users (Academics & Government Institutes, Biotechnology & Pharma Companies, Hospitals)
Hospitals segment is estimated to gain the largest market share of about 42% in the year 2037. The healthcare industry is expanding rapidly, with a significant number of patients contributing to the growth of the sector. There has been a notable increase in the number of hospitals, with approximately 6,100 hospitals in the United States by 2022. Hospitals offer a wide range of medical care, and with genome editing emerging as a major treatment for many illnesses, the hospitals segment is expected to continue to grow.
Our in-depth analysis of the global market includes the following segments:
|
Application |
|
|
End Users |
|
|
Technology |
|
|
Delivery |
|
North American Market Forecast
The genome editing market in North America is expected to dominate over the forecast period accounting for 35% of the revenue share. The growth in the region is primarily due to an increase in population and research activity, as well as the availability of health insurance that covers various cancer diagnoses and related genome editing. Patients' ability to afford advanced treatments and the rising economic status in the region are expected to further drive market growth during the forecast period. In August 2022, personal income in the U.S. grew by 0.3% to reach USD 71.6 billion, while personal spending grew by 0.4% to reach USD 6.75 billion, according to the U.S. Bureau of Economic Analysis.
APAC Statistics
The Asia Pacific genome editing market is expected to hold a large share of about 24%. This is due to the region having the fastest ageing population in the world, with an estimated 1.3 billion geriatric population by 2050. The rise in cancer patients and deaths, along with funding for medical infrastructure, are also expected to contribute to market growth.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?